← All trials
NCT04864522
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2021
- Primary completion
- Jan 1, 2026
- Completion date
- Jan 1, 2027
- First posted
- Apr 29, 2021
- Last posted
- Apr 29, 2021
- Enrollment
- 25
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of VirginiaLead sponsor
- University of VirginiaReponsible party - principal investigator
- University of VirginiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.